Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaAlan J. Thompson, Jeffrey A. Cohen, Brenda Banwell et al.|The Lancet Neurology|2017Cited by 8k
International consensus diagnostic criteria for neuromyelitis optica spectrum disordersDean M. Wingerchuk, Brian G. Weinshenker, Patrick Waters et al.|Neurology|2015Cited by 4.6k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple SclerosisStephen L. Hauser, Ludwig Kappos, Amit Bar‐Or et al.|New England Journal of Medicine|2016Cited by 2k
Ocrelizumab versus Placebo in Primary Progressive Multiple SclerosisXavier Montalbán, Jerry S. Wolinsky, Stephen L. Hauser et al.|New England Journal of Medicine|2016Cited by 1.9k
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosisMike P. Wattjes, Olga Ciccarelli, Daniel S. Reich et al.|The Lancet Neurology|2021Cited by 646